Cargando…
Plasma biomarkers for neurodegenerative disorders: ready for prime time?
Several plasma biomarkers for Alzheimer's disease and related disorders (ADRD) have demonstrated clinical and technical robustness. However, are they ready for clinical implementation? This review critically appraises current evidence for and against the immediate use of plasma biomarkers in cl...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872855/ https://www.ncbi.nlm.nih.gov/pubmed/36607770 http://dx.doi.org/10.1097/YCO.0000000000000851 |